Michael R Megna is CHIEF ACCOUNTING OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 26,528 shares of KNSA, which is worth approximately $530,825. The most recent transaction as insider was on Jun 30, 2020, when has been sold 641 shares (Class A Common Share) at a price of $9.51 per share, resulting in proceeds of $6,096. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.5K
0.35% 3M change
56.0% 12M change
Total Value Held $530,825

Michael R Megna Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2020
BUY
Grant, award, or other acquisition
$6,096 $9.51 p/Share
641 Added 26.5%
1,778 Class A Common Share
MRM

Michael R Megna

CHIEF ACCOUNTING OFFICER
Hamilton, D0

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA